Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men (Q74287080)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

M Dumont

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Mauriège

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Bergeron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J P Després

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D Prud'homme

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1136-1143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

Consensus conference. Lowering blood cholesterol to prevent heart disease

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Health risks of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Adiposity, fat distribution, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

New lipid lowering drugs and new effects of old drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

The gross composition of the body

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

A new colorimetric micro-determination of free fatty acids in serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Are apolipoproteins better discriminators than lipids for atherosclerosis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

The fibrates in clinical practice: focus on micronised fenofibrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Reappraisal of the role of insulin in hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Resistance to insulin but not to glucagon in lean human hypertriglyceridemics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Influence of Gemfibrozil and Clofibrate on Metabolism of Cholesterol and Plasma Triglycerides in Man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Prospective analysis of the insulin-resistance syndrome (syndrome X).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0801665

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0801665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11477498%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference